192 related articles for article (PubMed ID: 22791286)
1. SOCS3 is an endogenous inhibitor of pathologic angiogenesis.
Stahl A; Joyal JS; Chen J; Sapieha P; Juan AM; Hatton CJ; Pei DT; Hurst CG; Seaward MR; Krah NM; Dennison RJ; Greene ER; Boscolo E; Panigrahy D; Smith LE
Blood; 2012 Oct; 120(14):2925-9. PubMed ID: 22791286
[TBL] [Abstract][Full Text] [Related]
2. Calpastatin counteracts pathological angiogenesis by inhibiting suppressor of cytokine signaling 3 degradation in vascular endothelial cells.
Miyazaki T; Taketomi Y; Saito Y; Hosono T; Lei XF; Kim-Kaneyama JR; Arata S; Takahashi H; Murakami M; Miyazaki A
Circ Res; 2015 Mar; 116(7):1170-81. PubMed ID: 25648699
[TBL] [Abstract][Full Text] [Related]
3. Opposite angiogenic outcome of curcumin against ischemia and Lewis lung cancer models: in silico, in vitro and in vivo studies.
Fan S; Xu Y; Li X; Tie L; Pan Y; Li X
Biochim Biophys Acta; 2014 Sep; 1842(9):1742-54. PubMed ID: 24970744
[TBL] [Abstract][Full Text] [Related]
4. Direct endothelial junction restoration results in significant tumor vascular normalization and metastasis inhibition in mice.
Agrawal V; Maharjan S; Kim K; Kim NJ; Son J; Lee K; Choi HJ; Rho SS; Ahn S; Won MH; Ha SJ; Koh GY; Kim YM; Suh YG; Kwon YG
Oncotarget; 2014 May; 5(9):2761-77. PubMed ID: 24811731
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of 2-oxoglutarate through inhibition of angiogenesis in a murine tumor model.
Matsumoto K; Obara N; Ema M; Horie M; Naka A; Takahashi S; Imagawa S
Cancer Sci; 2009 Sep; 100(9):1639-47. PubMed ID: 19575748
[TBL] [Abstract][Full Text] [Related]
6. Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon.
Rigby RJ; Simmons JG; Greenhalgh CJ; Alexander WS; Lund PK
Oncogene; 2007 Jul; 26(33):4833-41. PubMed ID: 17297444
[TBL] [Abstract][Full Text] [Related]
7. SOCS3 blocks HIF-1α expression to inhibit proliferation and angiogenesis of human small cell lung cancer by downregulating activation of Akt, but not STAT3.
Wan J; Che Y; Kang N; Wu W
Mol Med Rep; 2015 Jul; 12(1):83-92. PubMed ID: 25695729
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin S from both tumor and tumor-associated cells promote cancer growth and neovascularization.
Small DM; Burden RE; Jaworski J; Hegarty SM; Spence S; Burrows JF; McFarlane C; Kissenpfennig A; McCarthy HO; Johnston JA; Walker B; Scott CJ
Int J Cancer; 2013 Nov; 133(9):2102-12. PubMed ID: 23629809
[TBL] [Abstract][Full Text] [Related]
9. Nuclear receptor RORα regulates pathologic retinal angiogenesis by modulating SOCS3-dependent inflammation.
Sun Y; Liu CH; SanGiovanni JP; Evans LP; Tian KT; Zhang B; Stahl A; Pu WT; Kamenecka TM; Solt LA; Chen J
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10401-6. PubMed ID: 26243880
[TBL] [Abstract][Full Text] [Related]
10. Pre-treatment of recombinant mouse MFG-E8 downregulates LPS-induced TNF-α production in macrophages via STAT3-mediated SOCS3 activation.
Aziz M; Jacob A; Matsuda A; Wu R; Zhou M; Dong W; Yang WL; Wang P
PLoS One; 2011; 6(11):e27685. PubMed ID: 22114683
[TBL] [Abstract][Full Text] [Related]
11. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production.
Ogata H; Chinen T; Yoshida T; Kinjyo I; Takaesu G; Shiraishi H; Iida M; Kobayashi T; Yoshimura A
Oncogene; 2006 Apr; 25(17):2520-30. PubMed ID: 16474852
[TBL] [Abstract][Full Text] [Related]
12. Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line.
Ruscica M; Ricci C; Macchi C; Magni P; Cristofani R; Liu J; Corsini A; Ferri N
J Biol Chem; 2016 Feb; 291(7):3508-19. PubMed ID: 26668321
[TBL] [Abstract][Full Text] [Related]
13. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission.
Xu AT; Li Y; Zhao D; Shen J; Xu XT; Qiao YQ; Zhu MM; Wang TR; Cui Y; Ai LY; Ran ZH
Inflamm Bowel Dis; 2015 Feb; 21(2):241-50. PubMed ID: 25545374
[TBL] [Abstract][Full Text] [Related]
14. Suppressor of cytokine signaling-3 suppresses the ability of activated signal transducer and activator of transcription-3 to stimulate neurite growth in rat primary sensory neurons.
Miao T; Wu D; Zhang Y; Bo X; Subang MC; Wang P; Richardson PM
J Neurosci; 2006 Sep; 26(37):9512-9. PubMed ID: 16971535
[TBL] [Abstract][Full Text] [Related]
15. Loss of stromal JUNB does not affect tumor growth and angiogenesis.
Braun J; Strittmatter K; Nübel T; Komljenovic D; Sator-Schmitt M; Bäuerle T; Angel P; Schorpp-Kistner M
Int J Cancer; 2014 Mar; 134(6):1511-6. PubMed ID: 24027048
[TBL] [Abstract][Full Text] [Related]
16. SOCS3 promotor hypermethylation and STAT3-NF-κB interaction downregulate SOCS3 expression in human coronary artery smooth muscle cells.
Dhar K; Rakesh K; Pankajakshan D; Agrawal DK
Am J Physiol Heart Circ Physiol; 2013 Mar; 304(6):H776-85. PubMed ID: 23335796
[TBL] [Abstract][Full Text] [Related]
17. Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation.
Qin H; Yeh WI; De Sarno P; Holdbrooks AT; Liu Y; Muldowney MT; Reynolds SL; Yanagisawa LL; Fox TH; Park K; Harrington LE; Raman C; Benveniste EN
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):5004-9. PubMed ID: 22411837
[TBL] [Abstract][Full Text] [Related]
18. Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling.
Shi H; Tzameli I; Bjørbaek C; Flier JS
J Biol Chem; 2004 Aug; 279(33):34733-40. PubMed ID: 15181014
[TBL] [Abstract][Full Text] [Related]
19. Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development.
Mamlouk S; Kalucka J; Singh RP; Franke K; Muschter A; Langer A; Jakob C; Gassmann M; Baretton GB; Wielockx B
Int J Cancer; 2014 Feb; 134(4):849-58. PubMed ID: 23913502
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone I inhibits tumor angiogenesis by reducing Stat3 phosphorylation at Tyr705 and hypoxia-induced HIF-1α accumulation in both endothelial and tumor cells.
Wang Y; Li JX; Wang YQ; Miao ZH
Oncotarget; 2015 Jun; 6(18):16031-42. PubMed ID: 26202747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
